ARCHIVES

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

This article is from The Cancer Letter archive.

Vol. 34 No. 38 | October 17, 2008

Download PDF Visit The Full Archive

Related Articles

Adjuvant BC Therapy Is Topic Of NIH Consensus Conference.

January 28, 2000

UPCI Recruits Shin To Lead Head & Neck Cancer Program.

April 27, 2001

NSABP Researcher Committed Misconduct, NIH Investigation Finds

March 18, 1994

Cancer Centers Form Network To Compete For Managed Care, Develop Standards

January 27, 1995

South African Investigator Bezwoda Admits Falsifying Data In High-Dose Chemo Study.

February 11, 2000

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

February 11, 1994